Recombinant rabies virus vaccine with molecular adjuvant induces strong immune responses and protection in mice Post author: Post published:October 24, 2023 Post category:uncategorized This study aimed to improve the effectiveness of the rabies vaccine to help alleviate and eliminate the rabies epidemic. You Might Also Like New AI imaging technique enhances retinal disorder diagnosis September 12, 2024 Study reveals positive impact of repeat COVID-19 vaccinations May 19, 2024 The positive impact of ULEZ on children’s health and environment September 5, 2024